Recombinant factor VIIa (Novoseven[reg ]) and the safety of treatment

Seminars in Hematology ◽

10.1053/shem.2001.29512 ◽

2001 ◽

Vol 38 (4F) ◽

pp. 48-50 ◽

Author(s):

Harold R. Roberts

Keyword(s):

Recombinant Factor Viia ◽

Download Full-text

Human Recombinant Factor VIIA is Neuroprotective in a Model of Traumatic Brain Injury and Secondary Hypoxemia

PsycEXTRA Dataset ◽

10.1037/e451562006-001 ◽

2004 ◽

Author(s):

R. A. Bauman ◽

J. B. Long ◽

L. H. Ketchum ◽

V. W. Macdonald

Keyword(s):

Traumatic Brain Injury ◽

Brain Injury ◽

Recombinant Factor Viia ◽

Download Full-text

Regular prophylaxis with recombinant factor VIIa in a patient with severe congenital FVII deficiency

Hämostaseologie ◽

10.1055/s-0037-1617127 ◽

2008 ◽

Vol 28 (S 01) ◽

pp. S55-S55 ◽

Author(s):

P. Lages ◽

R. Zimmermann ◽

A. Huth-Kühne

Keyword(s):

Recombinant Factor Viia ◽

Factor Viia ◽

Fvii Deficiency

Download Full-text

Management of Bleeding Using Recombinant Factor VIIa in a Patient Suffering from Bleeding Tendency due to a Lupus Anticoagulant-hypoprothrombinemia Syndrome

Thrombosis and Haemostasis ◽

10.1055/s-0037-1614919 ◽

1999 ◽

Vol 82 (12) ◽

pp. 1776-1778 ◽

Author(s):

Mette Holm ◽

Rinette Andreasen ◽

Jørgen Ingerslev

Keyword(s):

Lupus Anticoagulant ◽

Recombinant Factor Viia ◽

Factor Viia ◽

Bleeding Tendency

Download Full-text

Extrinsic Coagulation Pathway Inhibitor during Recombinant Factor VIIa Infusion

Thrombosis and Haemostasis ◽

10.1055/s-0038-1647134 ◽

1989 ◽

Vol 62 (04) ◽

pp. 1146-1146 ◽

Author(s):

Per Morten Sandset ◽

Ulrich Abildgaard ◽

Ulla Hedner ◽

Hans Johansson

Keyword(s):

Recombinant Factor Viia ◽

Factor Viia ◽

Coagulation Pathway

Download Full-text

Clinical Study of Recombinant Factor VIIa (NN-007) in Hemophilia Patients with Inhibitors

Japanese Journal of Thrombosis and Hemostasis ◽

10.2491/jjsth.5.158 ◽

1994 ◽

Vol 5 (3) ◽

pp. 158-172 ◽

Author(s):

Hidehiko SAITO ◽

Junki TAKAMATSU ◽

Tadashi KAMIYA ◽

Katsuyuki FUKUTAKE ◽

Tetsuya YAMAGISHI ◽

...

Keyword(s):

Clinical Study ◽

Recombinant Factor Viia ◽

Download Full-text

Faculty Opinions recommendation of Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.10017956.10757054 ◽

2011 ◽

Author(s):

Thomas Slaughter

Keyword(s):

Systematic Review ◽

Recombinant Factor Viia ◽

Factor Viia ◽

Off Label ◽

Download Full-text

Faculty Opinions recommendation of Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1048403.500313 ◽

2007 ◽

Author(s):

John Feiner

Keyword(s):

Liver Transplantation ◽

Liver Disease ◽

Chronic Liver Disease ◽

Recombinant Factor Viia ◽

Factor Viia ◽

Chronic Liver ◽

Bolus Administration ◽

Safety And Efficacy ◽

Download Full-text

Faculty Opinions recommendation of Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1064850.517786 ◽

2007 ◽

Author(s):

Louis Aledort

Keyword(s):

Clinical Trials ◽

Adjunctive Therapy ◽

Recombinant Factor Viia ◽

Factor Viia ◽

Trauma Patients ◽

Severely Injured ◽

Bleeding Control ◽

Download Full-text

Faculty Opinions recommendation of Off-label use of recombinant factor VIIa in U.S. hospitals: analysis of hospital records.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.11034956.11983054 ◽

2011 ◽

Author(s):

A Koneti Rao

Keyword(s):

Recombinant Factor Viia ◽

Factor Viia ◽

Off Label Use ◽

Hospital Records ◽

Off Label ◽

Download Full-text

Faculty Opinions recommendation of A multicenter, randomized, double-blind, placebo-controlled, dose-escalation trial assessing safety and efficacy of active site inactivated recombinant factor VIIa in subjects with acute lung injury or acute respiratory distress syndrome.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1162202.622674 ◽

2009 ◽

Author(s):

Michael O'Connor

Keyword(s):

Acute Respiratory Distress Syndrome ◽

Acute Lung Injury ◽

Lung Injury ◽

Active Site ◽

Distress Syndrome ◽

Recombinant Factor Viia ◽

Factor Viia ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo

Download Full-text